Cytochrome P450 17A1 Inhibitors

Name
Cytochrome P450 17A1 Inhibitors
Accession Number
DBCAT003461  (DBCAT004356)
Description

Not Available

Drugs
DrugDrug Description
AbirateroneAn antiandrogen used in the treatment of metastatic castration-resistant prostate cancer and metastatic high-risk castration-sensitive prostate cancer.
Drugs & Drug Targets
DrugTargetType
AbirateroneSteroid 17-alpha-hydroxylase/17,20 lyasetarget
AbirateroneSerum albumincarrier
AbirateroneAlpha-1-acid glycoprotein 1carrier
AbirateroneCytochrome P450 3A4enzyme
AbirateroneBile salt sulfotransferaseenzyme
AbirateroneMultidrug resistance-associated protein 1transporter
AbirateroneCytochrome P450 2D6enzyme
AbirateroneCytochrome P450 2C8enzyme
AbirateroneCytochrome P450 1A2enzyme
AbirateroneCytochrome P450 2C19enzyme
AbirateroneCytochrome P450 2C9enzyme
AbirateroneCytochrome P450 3A5enzyme
AbirateroneSolute carrier organic anion transporter family member 1B1transporter